Skip to main content
. 2019 Apr 26;9(5):82. doi: 10.3390/metabo9050082

Table 2.

Upregulated gene sets involved in the metabolism of polar metabolites in the LNCAP cell line and prostate adenocarcinoma patients.

Gene Sets LNCAP Prostate Adenocarcinoma
Number ES p-value FDR Number ES p-value FDR
Arginine and Proline Metabolism 17 (49) −0.38 0 0.11 14 (52) −0.31 0.53 0.94
Ascorbate and Aldarate Metabolism 11 (18) −0.61 0 0.18 8 (16) −0.61 0.21 1.00
Histidine Metabolism 12 (27) −0.42 0 0.13 5 (28) −0.24 0.88 0.97
Nicotinate and Nicotinamide Metabolism 8 (21) −0.33 0 0.15 7 (22) −0.28 0.83 0.99
Pentose and Glucuronate Interconversions 7 (20) −0.54 0 0.17 8 (18) −0.63 0.14 1.00
Pentose Phosphate Pathway 9 (25) −0.36 0 0.10 18 (26) −0.20 0.97 0.98
Phenylalanine Metabolism 10 (18) −0.49 0 0.12 6 (18) −0.40 0.50 0.99
Retinol Metabolism 17 (48) −0.48 0 0.10 20 (54) −0.42 0.59 0.98
Starch and Sucrose Metabolism 13 (41) −0.41 0 0.10 8 (43) −0.38 0.47 0.97
Tyrosine Metabolism 14 (38) −0.52 0 0.10 13 (42) −0.40 0.40 0.99
Butanoate Metabolism 10 (30) −0.41 0.09 0.13 8 (34) −0.39 0.29 0.95
Glycine Serine and Threonine Metabolism 12 (29) −0.40 0.10 0.18 4 (31) −0.31 0.76 1.00
Tryptophan Metabolism 15 (37) −0.34 0.10 0.30 8 (39) −0.27 0.81 0.97
Valine Leucine and Isoleucine Degradation 20 (44) −0.31 0.30 0.33 12 (44) −0.35 0.31 0.99
Amino Sugar and Nucleotide Sugar Metabolism 14 (43) −0.22 0.31 0.42 18 (44) −0.33 0.40 0.99

Note: Number: number of genes contributing to the leading-edge subset within the gene set (number of genes in the gene set after filtering out these genes not in the expression dataset); ES: enrichment score; p-value: nominal p-value not adjusted for gene set size or multiple hypothesis testing; a p-value of zero (0) indicates an actual p-value of less than 0.001; and FDR: false discovery rate.